Cleared Traditional

K833850 - T4 RIA

K833850 is an FDA 510(k) clearance for T4 RIA, manufactured by Syncor Intl. Corp.. The device is a Class 2 Chemistry device with product code CDX cleared through the Traditional 510(k) pathway after a 75-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
75d
Days
Class 2
Risk

K833850 is an FDA 510(k) clearance for the T4 RIA. Classified as Radioimmunoassay, Total Thyroxine (product code CDX), Class II - Special Controls.

Submitted by Syncor Intl. Corp. (Mchenry, US). The FDA issued a Cleared decision on January 18, 1984 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1700 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K833850

510(k) Number K833850 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 04, 1983
Decision Date January 18, 1984
Days to Decision 75 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 89d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDX Device Classification - Class 2, Special Controls

Product Code CDX Radioimmunoassay, Total Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDX Radioimmunoassay, Total Thyroxine

All 120
Devices cleared under the same product code (CDX) and FDA review panel - the closest regulatory comparables to K833850.
PANCOAT T4 COATED TUBE RADIOIMMUNOASSAY KIT
K854324 · Pantex, Div. Bio-Analysis, Inc. · Dec 1985
IMMPULSE T4 ASSAY REAGENTS
K840852 · Paragon Diagnostics, Inc. · Apr 1984
BIO-SCIENCE LABORATORIES T4 REAGENT
K834023 · Biosan Laboratories, Inc. · Jan 1984
RIACOAT T-4
K833745 · Immuno Assay Corp. · Jan 1984
T4-RIA SINGLE REAGENT
K832468 · Fairlake Laboratories · Sep 1983
MAGIC T4 125I RADIOIMMUNOASSAY
K831533 · Corning Medical & Scientific · Jun 1983